Role and clinicopathologic significance of CXC chemokine ligand 16 and chemokine (C-X-C motif) receptor 6 expression in gastric carcinomas

Human Pathology

Volumn 43, Issue 12, 2012, Pages 2299-2307

  Xing, Ya Nan ^a   Xu, Xiao Yan ^a   Nie, Xiao Cui ^a   Yang, Xue ^a   Yu, Miao ^a   Xu, Hui Mian ^a   Liu, Yun Peng ^a   Takano, Yasuo ^b   Zheng, Hua Chuan ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

^b KANAGAWA CANCER CENTER   (Japan)

Author keywords

CXCL16; CXCR6; Gastric carcinoma

Indexed keywords

CHEMOKINE RECEPTOR CXCR6; CXCL16 CHEMOKINE;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER PROGNOSIS; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEX DIFFERENCE; STOMACH CARCINOMA; TISSUE MICROARRAY; WESTERN BLOTTING;

AGE FACTORS; AGED; CARCINOMA; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; CHEMOKINES, CXC; DISEASE PROGRESSION; FEMALE; GASTRIC MUCOSA; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; RECEPTORS, CHEMOKINE; RECEPTORS, SCAVENGER; RECEPTORS, VIRUS; SEX FACTORS; STOMACH; STOMACH NEOPLASMS;

EID: 84869493232     PISSN: 00468177     EISSN: 15328392     Source Type: Journal    
DOI: 10.1016/j.humpath.2011.08.027     Document Type: Article

References (19)

1. J.R. Kelley, and J.M. Duggan Gastric cancer epidemiology and risk factors J Clin Epidemiol 56 2003 1 9
2. K.D. Crew, and A.I. Neugut Epidemiology of gastric cancer World J Gastroenterol 12 2006 354 362
3. L. Deng, N. Chen, Y. Li, H. Zheng, and Q. Lei CXCR6/CXCL16 functions as a regulator in metastasis and progression of cancer Biochim Biophys Acta 1806 2010 42 49
4. + lymphocytes to inflamed liver J Immunol 174 2005 277 283
5. J. Wang, Y. Lu, J. Wang, A.E. Koch, J. Zhang, and R.S. Taichman CXCR6 induces prostate cancer progression by the AKT/mammalian target of rapamycin signaling pathway Cancer Res 68 2008 10367 10376
6. M. Darash-Yahana, J.W. Gillespie, and S.M. Hewitt The chemokine CXCL16 and its receptor, CXCR6, as markers and promoters of inflammation-associated cancers PLoS One 4 2009 e6695
7. J. Meijer, J. Ogink, B. Kreike, D. Nuyten, K.E. de Visser, and E. Roos The chemokine receptor CXCR6 and its ligand CXCL16 are expressed in carcinomas and inhibit proliferation Cancer Res 68 2008 4701 4708
8. H.K. Ha, W. Lee, H.J. Park, S.D. Lee, J.Z. Lee, and M.K. Chung Clinical significance of CXCL16/CXCR6 expression in patients with prostate cancer Mol Med Rep 4 2011 419 424
9. L. Guo, Z.M. Cui, J. Zhang, and Y. Huang Chemokine axes CXCL12/CXCR4 and CXCL16/CXCR6 correlate with lymph node metastasis in epithelial ovarian carcinoma Chin J Cancer 30 2011 336 343
10. P. Gutwein, A. Schramme, and N. Sinke Tumoural CXCL16 expression is a novel prognostic marker of longer survival times in renal cell cancer patients Eur J Cancer 45 2009 478 489
11. M.N. Wente, M.M. Gaida, and C. Mayer Expression and potential function of the CXC chemokine CXCL16 in pancreatic ductal adenocarcinoma Int J Oncol 33 2008 297 308
12. S. Hojo, K. Koizumi, and K. Tsuneyama High-level expression of chemokine CXCL16 by tumor cells correlates with a good prognosis and increased tumor-infiltrating lymphocytes in colorectal cancer Cancer Res 67 2007 4725 4731
13. L.H. Sobin, and C.H. Wittekind TNM classification of malignant tumors 6th ed 2002 John Wiley & Sons Hoboken, NJ
14. H.C. Zheng, X.H. Li, and T. Hara Mixed-type gastric carcinomas exhibit more aggressive features and indicate the histogenesis of carcinomas Virchows Arch 452 2008 525 534
15. T. Kumada, K. Tsuneyama, H. Hatta, S. Ishizawa, and Y. Takano Improved 1-h rapid immunostaining method using intermittent microwave irradiation: practicability based on 5 years application in Toyama Medical and Pharmaceutical University Hospital Mod Pathol 17 2004 1141 1149
16. Y. Lu, J. Wang, and Y. Xu CXCL16 functions as a novel chemotactic factor for prostate cancer cells in vitro Mol Cancer Res 6 2008 546 554
17. S. Lin, L. Sun, and J. Hu Chemokine C-X-C motif receptor 6 contributes to cell migration during hypoxia Cancer Lett 279 2009 108 117
18. W. Hu, X. Zhen, B. Xiong, B. Wang, W. Zhang, and W. Zhou CXCR6 is expressed in human prostate cancer in vivo and is involved in the in vitro invasion of PC3 and LNCap cells Cancer Sci 99 2008 1362 1369
19. A. Ludwig, C. Hundhausen, and M.H. Lambert Metalloproteinase inhibitors for the disintegrin-like metalloproteinases ADAM10 and ADAM17 that differentially block constitutive and phorbol ester-inducible shedding of cell surface molecules Comb Chem High Throughput Screen 8 2005 161 171